Immunic, Inc. (IMUX) will implement a 1-for-10 reverse stock split of its outstanding common shares, effective April 27, 2026.
The reverse split aims to help the company meet obligations under a securities purchase agreement signed with institutional and accredited investors on February 12, 2026.
In premarket trading, IMUX shares dropped 4.42% to $0.8602.
Oil prices surge past $110 per barrel while global stock markets fluctuate amid President Trump's looming deadline for Iran to…
The Making of a Rock Classic When guitarist Marc Ford joined The Black Crowes in 1992, the 26-year-old musician found…
Top 15 High-Growth Dividend Stocks for March 2026The latest selection of 15 top dividend growth stocks for March 2026 highlights…
Mitsubishi Gas Chemical Company, Inc. released its fiscal year 2025 third quarter results presentation, highlighting a net loss amid impairment…
